Trial intelligence / Profile preview

TPX-105 for Correction of Nasojugal Groove

NCT06197789Phase 3Completed

Sponsor
Tego Science
Start
Aug 2021
Primary completion
Jun 2023
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of Rosmir in tear trough deformity, sponsored by Tego Science. Started Aug 2021; status: completed.

02

Drugs

Rosmir
03

Conditions

tear trough deformity

Beyond the preview

Go deeper on NCT06197789.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06197789.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call